SCHEMBL8723747

SCHEMBL8723747

O=C1C(N2C(=O)c3ccccc3C2=O)=C(N2C(=O)c3ccccc3C2=O)C(=O)C(N2C(=O)c3ccccc3C2=O)=C1N1C(=O)c2ccccc2C1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
SCN2A Q99250 3/20 0.48
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
CASP3 P42574 1/20 0.48
CDC25B P30305 1/20 0.48
POLB P06746 3/20 0.47
HTT P42858 2/20 0.46
CES2 O00748 2/20 0.46
BCHE P06276 2/20 0.46
CES1 P23141 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
KDM4E B2RXH2 1/20 0.46
APAF1 O14727 1/20 0.46
TERT O14746 1/20 0.46
NPC1 O15118 1/20 0.46
PLIN1 O60240 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16296869 0.92 KMT2A (0.52) MEN1KMT2ASCN2ACA12CA1
SCHEMBL29259715 0.81 MEN1 (0.40) MEN1KMT2ASCN2ACA12CA1
SCHEMBL12015510 0.81 NR1H3 (0.41) MEN1KMT2ASCN2ACA12CA1
SCHEMBL12014768 0.81 MEN1 (0.40) MEN1KMT2ASCN2ACA12CA1
SCHEMBL28517468 0.80 ERCC1 (0.59) MEN1KMT2ACA12CA1CA2
SCHEMBL16231883 0.78 RAF1 (0.68) MEN1KMT2ACASP3CDC25BPOLB
SCHEMBL4649466 0.76 POLB (0.65) MEN1KMT2APOLBCES2BCHE
SCHEMBL4649471 0.76 KMT2A (0.78) MEN1KMT2ASCN2ACA12CA1
SCHEMBL19773976 0.74 KMT2A (0.68) MEN1KMT2ASCN2ACA12CA1
N-Phenyl-Phthalimide SCHEMBL123618 0.74 KMT2A (0.68) MEN1KMT2ASCN2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12505962-B2 Conductive two-dimensional (2D) covalent organic frameworks (COFS) and method of making an electrode material KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2025-12-23 US disclosed
US-20230197361-A1 CONDUCTIVE TWO-DIMENSIONAL (2D) COVALENT ORGANIC FRAMEWORKS (COFS) AND METHOD OF MAKING AN ELECTRODE MATERIAL UNIV KING ABDULLAH SCI & TECH (SA) 2023-06-22 US disclosed
US-10270101-B2 Electrode active material for power storage device, and power storage device PANASONIC CORPORATION (JP) 2019-04-23 US disclosed
US-20190055193-A1 High-Solubility Thioether Quinones U.S. DEPARTMENT OF ENERGY 2019-02-21 US disclosed
US-20150295244-A1 ELECTRODE ACTIVE MATERIAL FOR POWER STORAGE DEVICE, AND POWER STORAGE DEVICE PANASONIC CORPORATION (JP) 2015-10-15 US disclosed
US-20150295244-A1 ELECTRODE ACTIVE MATERIAL FOR POWER STORAGE DEVICE, AND POWER STORAGE DEVICE PANASONIC CORPORATION (JP) 2015-10-15 US disclosed
EP-0662004-B1 USE OF PERSISTENT FREE-RADICALS IN MAGNETIC RESONANCE IMAGING NYCOMED INNOVATION AB (SE) 1998-03-18 EP disclosed
US-5700448-A Use of persistent free-radicals in magnetic resonance imaging NYCOMED IMAGING AS (NO) 1997-12-23 US disclosed
US-5435991-A Use of persistent heterocyclic free-radicals in magnetic resonance imaging NYCOMED INNOVATION AB (SE) 1995-07-25 US disclosed
EP-0662004-A1 USE OF PERSISTENT FREE-RADICALS IN MAGNETIC RESONANCE IMAGING Nycomed Innovation AB (SE) 1995-07-12 EP disclosed
WO-1993002711-A1 USE OF PERSISTENT FREE-RADICALS IN MAGNETIC RESONANCE IMAGING NYCOMED INNOVATION AB (SE) 1993-02-18 WO disclosed
US-4581349-A Certain benzodiimidazoles and their use as radiation sensitizers UNIVERSITY OF MARYLAND (US) 1986-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10270101-B2 Electrode active material for power storage device, and power storage device HCN2, POLQ, KCNN2 MEN1 2127/4885KMT2A 461/4885SCN2A 319/4885
US-12505962-B2 Conductive two-dimensional (2D) covalent organic frameworks (COFS) and method of making an electrode material TET3, TET1, ALKBH2 MEN1 4827/4885KMT2A 214/4885SCN2A 241/4885
US-20190055193-A1 High-Solubility Thioether Quinones SQOR, TST, NDUFS3 MEN1 4210/4885KMT2A 1879/4885SCN2A 2904/4885
US-20150295244-A1 ELECTRODE ACTIVE MATERIAL FOR POWER STORAGE DEVICE, AND POWER STORAGE DEVICE NDUFV2, NDUFA2, SSBP1 MEN1 3722/4885KMT2A 909/4885SCN2A 284/4885
US-20230197361-A1 CONDUCTIVE TWO-DIMENSIONAL (2D) COVALENT ORGANIC FRAMEWORKS (COFS) AND METHOD OF MAKING AN ELECTRODE MATERIAL TET3, TET1, ALKBH2 MEN1 4827/4885KMT2A 214/4885SCN2A 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.